 Home > Active Ingredient News > Blood System > Clin Cancer Res: Long-term prognosis of Tislelizumab in the treatment of relapsed/refractory classic Hodgkin's lymphoma

Clin Cancer Res: Long-term prognosis of Tislelizumab in the treatment of relapsed/refractory classic Hodgkin's lymphoma

 Last Update: 2021-12-01
 Source: Internet
 Author: User

Tags

meclizine side effects

long side effects epinephrine

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Classical Hodgkin’s lymphoma (cHL) is characterized by the rare malignant Hodgkin’s lymphoma RS (HRS) cells are surrounded by extensive inflammation and immune cell infiltration, such as T cells, macrophages, neutrophils and B cells

Lymphoma Immune Tumor Immune

Tislelizumab is an anti-programmed death protein 1 (anti-PD-1) monoclonal antibody specifically designed to reduce the binding of PD-1 to Fcγ receptors (FcγR)

This article reports the results of a phase II clinical trial of Tislelizumab for the treatment of 70 patients with relapsed/refractory classic Hodgkin’s lymphoma and extended follow-up for 3 years

stem cell

The overall progression-free survival rate of the tested patients

The median follow-up was 33.

The overall remission rate was 87.

Progression-free survival rate of patients with or without a history of autologous stem cell transplantation

97.

Related biomarker analysis showed that FcγRI-expressing macrophages had no significant effect on the remission rate and progression-free survival of Tislelizumab treatment

In summary, through extended follow-up, the study confirmed that Tislelizumab has long-term survival benefits and good safety in patients with relapsed/refractory cHL

Tislelizumab has long-term survival benefits and good safety in patients with relapsed/refractory cHL.

Original source:

Song Yuqin,Gao Quanli,Zhang Huilai et al.

Tislelizumab for relapsed / refractory classical Hodgkin lymphoma : 3-year follow-up and correlative biomarker analysis

in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

China Largest Manufacturer Supply High Purity Etamsylate CAS 2624-44-4

CAS No.: 2624-44-4

Pharmacy Grade

$3-3.5/KG FOB

Factory Supply Clarithromycin with High Quality 201530-41- 8

CAS No.: 201530-41-8

Pharmacy Grade

$3-3.5/KG FOB

Ferrous Fumarate

CAS No.: 141-01-5

Feed Grade

$5.8/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.